Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuemin Xue

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Diagnostic Pathology|September 7, 2019
Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature reviewLinxiu Liu, Xuemin Xue, Liyan Xue
Therapeutic Advances in Medical Oncology|January 22, 2024
MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literaturePei Yuan, Xuemin Xue, Tian Qiu, et al.
Annals of Hematology|December 1, 2023
Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOSZheng Cao, Xiaojun Wang, Xuemin Xue, et al.
Virchows Archiv : an International Journal of Pathology|December 4, 2024
High expression of RHOF is an effective diagnostic marker and a potential prognostic indicator for primary mediastinal large B-cell lymphomaXinyi Zhu, Lin Nong, Xuemin Xue, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 25, 2014
Diffuse large B-cell lymphoma: sub-classification by massive parallel quantitative RT-PCRXuemin Xue, Naiyan Zeng, Zifen Gao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 8, 2014
[Clinicopathological analysis of 64 case of angioimmunoblastic T-cell lymphoma]Congyou Gu, Nan Li, Min Li, et al.
American Journal of Cancer Research|May 9, 2022
The interaction of <i>p53</i> and DNA repair gene mutations and their impact on tumor mutation burden and immune response in human malignanciesXuemin Xue, Lin Dong, Edwina Burke, et al.
BMC Cancer|August 29, 2020
DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutationXuemin Xue, Wenting Huang, Tian Qiu, et al.
Annals of Hematology|October 4, 2021
Characterization of molecular genetics and clinicopathology in thymic MALT lymphomaXiaojun Wang, Yi Miao, Zheng Cao, et al.
BMC Cancer|December 6, 2017
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphomaWenting Huang, Xuemin Xue, Ling Shan, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Diagnostic Pathology|September 7, 2019
Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature reviewLinxiu Liu, Xuemin Xue, Liyan Xue
Therapeutic Advances in Medical Oncology|January 22, 2024
MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literaturePei Yuan, Xuemin Xue, Tian Qiu, et al.
Annals of Hematology|December 1, 2023
Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOSZheng Cao, Xiaojun Wang, Xuemin Xue, et al.
Virchows Archiv : an International Journal of Pathology|December 4, 2024
High expression of RHOF is an effective diagnostic marker and a potential prognostic indicator for primary mediastinal large B-cell lymphomaXinyi Zhu, Lin Nong, Xuemin Xue, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 25, 2014
Diffuse large B-cell lymphoma: sub-classification by massive parallel quantitative RT-PCRXuemin Xue, Naiyan Zeng, Zifen Gao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 8, 2014
[Clinicopathological analysis of 64 case of angioimmunoblastic T-cell lymphoma]Congyou Gu, Nan Li, Min Li, et al.
American Journal of Cancer Research|May 9, 2022
The interaction of <i>p53</i> and DNA repair gene mutations and their impact on tumor mutation burden and immune response in human malignanciesXuemin Xue, Lin Dong, Edwina Burke, et al.
BMC Cancer|August 29, 2020
DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutationXuemin Xue, Wenting Huang, Tian Qiu, et al.
Annals of Hematology|October 4, 2021
Characterization of molecular genetics and clinicopathology in thymic MALT lymphomaXiaojun Wang, Yi Miao, Zheng Cao, et al.
BMC Cancer|December 6, 2017
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphomaWenting Huang, Xuemin Xue, Ling Shan, et al.
Pageof 5